Home/Filings/5/0001387131-21-002306
5//SEC Filing

SAENGER BRADLEY 5

Accession 0001387131-21-002306

CIK 0001430306other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:32 PM ET

Size

4.9 KB

Accession

0001387131-21-002306

Insider Transaction Report

Form 5
Period: 2020-12-31
SAENGER BRADLEY
Chief Financial Officer
Transactions
  • Award

    Common Stock, par value $0.001

    2020-01-06$1.02/sh+493$5031,397 total
Footnotes (1)
  • [F1]Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2019 Employee Stock Purchase Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001668150

Filing Metadata

Form type
5
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:32 PM ET
Size
4.9 KB